Fundraising FoxAXXAM
Bresso, IT · 1 known investors
Find your way into AXXAM
Sign up to see every warm intro you have to AXXAM
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AXXAM team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Axxam develops AXXSense, a cell-based platform for assessing taste and olfactory properties of pharmaceutical compounds during drug development. The platform uses human bitter taste receptors and trigeminal assays to predict bitterness and off-tastes early in the pipeline, helping pharmaceutical companies optimize formulations and reduce late-stage reformulation risks.
Investors · 1
Frequently asked questions
- What does AXXAM do?
- Axxam develops AXXSense, a cell-based platform for assessing taste and olfactory properties of pharmaceutical compounds during drug development. The platform uses human bitter taste receptors and trigeminal assays to predict bitterness and off-tastes early in the pipeline, helping pharmaceutical companies optimize formulations and reduce late-stage reformulation risks.
- Who are AXXAM's investors?
- AXXAM's investors include Keensight Capital.
- Where is AXXAM headquartered?
- AXXAM is headquartered in Bresso, IT.